Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Bladder Cancer

Free Subscription 09.05.2022 1 Ann R Coll Surg Engl 1 Asian J Anesthesiol 1 Asian J Urol 1 Asian Pac J Cancer Prev 1 Biol Pharm Bull 1 Biol Sex Differ 1 BJU Int 1 BMC Cancer 1 Cancer Cell Int 1 Cancer Imaging 1 Cancer Res 2 Cell Death Discov 1 Cephalalgia 1 Cold Spring Harb Mol Case Stud 1 Comput Math Methods Med 1 Epigenomics 1 ESMO Open 1 Eur J Cancer 1 Eur J Surg Oncol 1 Eur Urol 2 Eur Urol Oncol 1 Eur Urol Open Sci 1 Exp Mol Pathol 1 Front Oncol 1 Front Surg 1 Int J Urol 1 Int Urol Nephrol 1 Investig Clin Urol 1 J Biophotonics 1 J Clin Invest 2 J Histotechnol 1 J Nucl Med 1 J Oncol 1 J Vet Diagn Invest 1 Mol Oncol 1 Radiologia (Engl Ed) 1 Rev Esp Patol 1 Scand J Prim Health Care 1 Scand J Urol 3 Sci Rep 2 Technol Cancer Res Treat 1 Turk J Pediatr 1 Urologe A 4 Urology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann R Coll Surg Engl

1. KUMAR S, Kaundal P, Parmar K, Akif S, et al
   Bilateral obstructive megaureter with right lower ureteric urothelial carcinoma: a very rare coalition.
   Ann R Coll Surg Engl. 2022;104:e153-e155.
   PubMed         Abstract available
   
   

   
   Asian J Anesthesiol

2. CHOU CT, Yu SW, Lin TC
   Systematic Review and Meta-Analysis of Inguinal Versus Classic Obturator Nerve Block.
   Asian J Anesthesiol. 2022;60:1-10.
   PubMed         Abstract available
   
   

   
   Asian J Urol

3. THYAVIHALLY YB, Dev P, Waigankar S, Pednekar A, et al
   Intravesical bacillus Calmette-Guerin (BCG) in treating non-muscle invasive bladder cancer-analysis of adverse effects and effectiveness of two strains of BCG (Danish 1331 and Moscow-I).
   Asian J Urol. 2022;9:157-164.
   PubMed         Abstract available
   
   

   
   Asian Pac J Cancer Prev

4. AMER S, Ibrahim H, Elkordy M
   The Immunohistochemical Expression of SOX-10 in Urothelial Carcinoma and the Non Neoplastic Urothelium; and a Correlation with the Tumor Features.
   Asian Pac J Cancer Prev. 2022;23:1425-1432.
   PubMed         Abstract available
   
   

   
   Biol Pharm Bull

5. KUNIMITSU Y, Morio K, Hirata S, Yamamoto K, et al
   Effects of Proton Pump Inhibitors on Survival Outcomes in Patients with Metastatic or Unresectable Urothelial Carcinoma Treated with Pembrolizumab.
   Biol Pharm Bull. 2022;45:590-595.
   PubMed         Abstract available
   
   

   
   Biol Sex Differ

6. HAMADE A, Li D, Tyryshkin K, Xu M, et al
   Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer.
   Biol Sex Differ. 2022;13:19.
   PubMed         Abstract available
   
   

   
   BJU Int

7. YANAGISAWA T, Sato S, Hayashida Y, Okada Y, et al
   Do we need repeat TUR after en bloc resection for pT1 bladder cancer?
   BJU Int. 2022 Apr 29. doi: 10.1111/bju.15760.
   PubMed         Abstract available
   
   

   
   BMC Cancer

8. WEICKHARDT AJ, Lau DK, Hodgson-Garms M, Lavis A, et al
   Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer.
   BMC Cancer. 2022;22:478.
   PubMed         Abstract available
   
   

   
   Cancer Cell Int

9. LIU J, Chou Z, Li C, Huang K, et al
   ZBTB7A, a miR-144-3p targeted gene, accelerates bladder cancer progression via downregulating HIC1 expression.
   Cancer Cell Int. 2022;22:179.
   PubMed         Abstract available
   
   

   
   Cancer Imaging

10. BRICIO TGM, Gouvea GL, Barros RV, Chahud F, et al
    What is the impact of dynamic contrast-enhancement sequence in the Vesical Imaging, Reporting and Data System (VI-RADS)? A subgroup analysis.
    Cancer Imaging. 2022;22:20.
    PubMed         Abstract available
    
    

    
    Cancer Res

11. NI Z, Sun P, Zheng J, Wu M, et al
    JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Cancer Res. 2022;82:1789-1802.
    PubMed         Abstract available
    
    

    
    Cell Death Discov

12. YANG HJ, Liu T, Xiong Y
    Anti-cancer effect of LINC00478 in bladder cancer correlates with KDM1A-dependent MMP9 demethylation.
    Cell Death Discov. 2022;8:242.
    PubMed         Abstract available
    
    
13. LU Q, Yin H, Deng Y, Chen W, et al
    circDHTKD1 promotes lymphatic metastasis of bladder cancer by upregulating CXCL5.
    Cell Death Discov. 2022;8:243.
    PubMed         Abstract available
    
    

    
    Cephalalgia

14. LIU Y, Wei T
    Micturition-triggered severe headache associated with bladder paraganglioma: A case report.
    Cephalalgia. 2022;42:166-169.
    PubMed         Abstract available
    
    

    
    Cold Spring Harb Mol Case Stud

15. ALNAJAR H, Ravichandran H, Figueiredo Rendeiro A, Ohara K, et al
    Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab.
    Cold Spring Harb Mol Case Stud. 2022;8.
    PubMed         Abstract available
    
    

    
    Comput Math Methods Med

16. LI T, Xu Q, Wei Y, Lin R, et al
    Overexpression of miRNA-93-5p Promotes Proliferation and Migration of Bladder Urothelial Carcinoma via Inhibition of KLF9.
    Comput Math Methods Med. 2022;2022:8911343.
    PubMed         Abstract available
    
    

    
    Epigenomics

17. KELSEY K
    Epigenetics, environment and epidemiology: an interview with Karl Kelsey.
    Epigenomics. 2022;14:323-326.
    PubMed         Abstract available
    
    

    
    ESMO Open

18. IZAWA N, Shiokawa H, Onuki R, Hamaji K, et al
    The clinical utility of comprehensive measurement of autoimmune disease-related antibodies in patients with advanced solid tumors receiving immune checkpoint inhibitors: a retrospective study.
    ESMO Open. 2022;7:100415.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

19. KLUMPER N, Sikic D, Saal J, Buttner T, et al
    C-reactive protein flare predicts response to anti-PD-(L)1 immune checkpoint blockade in metastatic urothelial carcinoma.
    Eur J Cancer. 2022;167:13-22.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

20. CHECCUCCI E, Manfredi M, Sica M, Amparore D, et al
    Robot-assisted-radical-cystectomy with total intracorporeal Y neobladder: Analysis of postoperative complications and functional outcomes with urodynamics findings.
    Eur J Surg Oncol. 2022;48:694-702.
    PubMed         Abstract available
    
    

    
    Eur Urol

21. LAUKHTINA E, Shariat SF
    Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer.
    Eur Urol. 2022 Apr 30. pii: S0302-2838(22)01816.
    PubMed        
    
    

    
    Eur Urol Oncol

22. GROBET-JEANDIN E, Pinar U, Roupret M
    Upper Urinary Tract Urothelial Carcinoma in Lynch Syndrome Patients: The Urologist Still Has a Role in Genetic Screening.
    Eur Urol Oncol. 2022;5:42-43.
    PubMed        
    
    
23. LONATI C, Necchi A, Gomez Rivas J, Afferi L, et al
    Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors.
    Eur Urol Oncol. 2022;5:30-41.
    PubMed         Abstract available
    
    

    
    Eur Urol Open Sci

24. GORDON NS, Humayun-Zakaria N, Goel A, Abbotts B, et al
    STAG2 Protein Expression in Non-muscle-invasive Bladder Cancer: Associations with Sex, Genomic and Transcriptomic Changes, and Clinical Outcomes.
    Eur Urol Open Sci. 2022;38:88-95.
    PubMed         Abstract available
    
    

    
    Exp Mol Pathol

25. OBAIDULISLAM M, Bacchetti T, Berrougui H, AbdelouahedKhalil, et al
    Effect of glycated HDL on oxidative stress and cholesterol homeostasis in a human bladder cancer cell line, J82.
    Exp Mol Pathol. 2022 Apr 29:104777. doi: 10.1016/j.yexmp.2022.104777.
    PubMed         Abstract available
    
    

    
    Front Oncol

26. WU J, Xie RY, Cao CZ, Shang BQ, et al
    Disease Management of Clinical Complete Responders to Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer: A Review of Literature.
    Front Oncol. 2022;12:816444.
    PubMed         Abstract available
    
    

    
    Front Surg

27. TEOH JY, Castellani D
    Editorial: Recent Advances in Bladder Cancer Diagnosis and Treatment.
    Front Surg. 2022;9:890172.
    PubMed        
    
    

    
    Int J Urol

28. KANNO T, Kobori G, Ito K, Nakagawa H, et al
    Complications and their management following retroperitoneal lymph node dissection in conjunction with retroperitoneal laparoscopic radical nephroureterectomy.
    Int J Urol. 2022;29:455-461.
    PubMed         Abstract available
    
    

    
    Int Urol Nephrol

29. CHIERIGO F, Borghesi M, Wurnschimmel C, Flammia RS, et al
    Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity.
    Int Urol Nephrol. 2022 May 4. pii: 10.1007/s11255-022-03221.
    PubMed         Abstract available
    
    

    
    Investig Clin Urol

30. SUNG HH, Kim H, Kim R, Kim CK, et al
    Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder.
    Investig Clin Urol. 2022;63:168-174.
    PubMed         Abstract available
    
    

    
    J Biophotonics

31. TAIEB A, Berkovic G, Haifler M, Cheshnovsky O, et al
    Classification of tissue biopsies by Raman spectroscopy guided by quantitative phase imaging and its application to bladder cancer.
    J Biophotonics. 2022 Apr 30:e202200009. doi: 10.1002/jbio.202200009.
    PubMed         Abstract available
    
    

    
    J Clin Invest

32. ROUANNE M, Adam J, Radulescu C, Letourneur D, et al
    BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer.
    J Clin Invest. 2022 May 3. pii: 145666. doi: 10.1172/JCI145666.
    PubMed         Abstract available
    
    

    
    J Histotechnol

33. ABDELZAHER AHMED E, Abdel Bary Abdel-Latif A, Fahmy AM, Elzarrouk Mania I, et al
    Differential lysophosphatidylcholine acyltransferase 1 (LPCAT1) expression confers aggressiveness and independently predicts recurrence in bladder urothelial carcinomas.
    J Histotechnol. 2021;44:196-205.
    PubMed         Abstract available
    
    
34. SAMEH R, Mostafa N, Ramadan M, AbdelRaouf S, et al
    Prognostic significance of EZH2 and ARID1A expression in urothelial carcinoma: an immunohistochemical study.
    J Histotechnol. 2022;45:21-28.
    PubMed         Abstract available
    
    

    
    J Nucl Med

35. PARIHAR AS, Schmidt LR, Dehdashti F, Wahl RL, et al
    Detection of additional primary neoplasms on (18)F-Fluciclovine PET/CT in patients with primary prostate cancer.
    J Nucl Med. 2021 Aug 19. pii: jnumed.121.262647. doi: 10.2967/jnumed.121.262647.
    PubMed         Abstract available
    
    

    
    J Oncol

36. TAN Z, Fu S, Feng R, Huang Y, et al
    Identification of Potential Biomarkers for Progression and Prognosis of Bladder Cancer by Comprehensive Bioinformatics Analysis.
    J Oncol. 2022;2022:1802706.
    PubMed         Abstract available
    
    

    
    J Vet Diagn Invest

37. MAMMONE RM, Havis B, Royal A, Donnelly LL, et al
    Urothelial carcinoma with tonsillar metastasis in a dog.
    J Vet Diagn Invest. 2022;34:564-567.
    PubMed         Abstract available
    
    

    
    Mol Oncol

38. GUIMARAES-TEIXEIRA C, Lobo J, Miranda-Goncalves V, Barros-Silva D, et al
    Downregulation of m(6) A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness.
    Mol Oncol. 2022;16:1841-1856.
    PubMed         Abstract available
    
    

    
    Radiologia (Engl Ed)

39. MARTINEZ MAICAS H, Torregrosa Andres A
    Granulomatous renal affectation post-BCG treatment of bladder tumor.
    Radiologia (Engl Ed). 2022;64:179-181.
    PubMed        
    
    

    
    Rev Esp Patol

40. ULLDEMOLINS AZNAR P, Munoz Vicente E, Rosello-Sastre E
    [How has the Paris System contributed to urine cytology? Evaluating the contribution of the Paris System to urine cytology. A comparative study of the Paris System and the Papanicolaou method in a tertiary centre].
    Rev Esp Patol. 2022;55:125-134.
    PubMed         Abstract available
    
    

    
    Scand J Prim Health Care

41. JESSEN NH, Jensen H, Falborg AZ, Glerup H, et al
    Contacts to general practice in the 12 months preceding a diagnosis of an abdominal cancer: a national register-based cohort study.
    Scand J Prim Health Care. 2022;40:148-156.
    PubMed         Abstract available
    
    

    
    Scand J Urol

42. MOLLER CT, Fossa SD, Tafjord G, Babigumira R, et al
    Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment.
    Scand J Urol. 2022 May 4:1-7. doi: 10.1080/21681805.2022.2056633.
    PubMed         Abstract available
    
    

    
    Sci Rep

43. HOU J, Lu Z, Liu X, Luo B, et al
    Increased NUSAP1 expression is associated with lymph node metastasis and survival prognosis in bladder urothelial carcinoma.
    Sci Rep. 2022;12:7003.
    PubMed         Abstract available
    
    
44. CHUNG YH, Cheng YT, Kao YH, Tsai WC, et al
    MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by regulating WNT5A/beta-catenin signaling.
    Sci Rep. 2022;12:6955.
    PubMed         Abstract available
    
    
45. VAN HATTUM JW, Scutigliani EM, Helderman RFCPA, Zweije R, et al
    A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer.
    Sci Rep. 2022;12:7017.
    PubMed         Abstract available
    
    

    
    Technol Cancer Res Treat

46. CHEN J, Liao Y, Li R, Luo M, et al
    Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer.
    Technol Cancer Res Treat. 2022;21:15330338221090093.
    PubMed         Abstract available
    
    
47. LI Z, Feng N, Pu H, Dong Q, et al
    PIxel-Level Segmentation of Bladder Tumors on MR Images Using a Random Forest Classifier.
    Technol Cancer Res Treat. 2022;21:15330338221086395.
    PubMed         Abstract available
    
    

    
    Turk J Pediatr

48. TUNA R, Karaman S, Oktar T, Anak S, et al
    Bladder granulocytic sarcoma in a child: case report and literature review.
    Turk J Pediatr. 2022;64:152-159.
    PubMed         Abstract available
    
    

    
    Urologe A

49. SPEK A
    [Intravesical gemcitabine for non-muscle invasive bladder cancer].
    Urologe A. 2022 May 4. pii: 10.1007/s00120-022-01840.
    PubMed        
    
    

    
    Urology

50. DOUGLAWI A, Ghoreifi A, Lee R, Yip W, et al
    Bladder Recurrence Following Diagnostic Ureteroscopy in Patients Undergoing Nephroureterectomy for Upper Tract Urothelial Cancer: Is Ureteral Access Sheath Protective?
    Urology. 2022;160:142-146.
    PubMed         Abstract available
    
    
51. KUMARASEGARAM V, Drejer D, Jensen JB
    Detection Rate of Carcinoma In Situ During TURBT Following Shift from Photodynamic Diagnosis to Narrow Band Imaging in a Single University Hospital.
    Urology. 2022;161:83-86.
    PubMed         Abstract available
    
    
52. IPLIKCI A, Cakici MC, Simsek BC, Yildirim A, et al
    Lip Metastasis After Radical Cystectomy.
    Urology. 2022;161:17-18.
    PubMed        
    
    
53. SCHLOMER BJ, Norris N, Gurram B, Carpinito G, et al
    Bladder Necrosis at Time of Presentation with Ulcerative Colitis in an 8-year-old Female: A Case Report.
    Urology. 2022;160:195-198.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: